What changed
$SNDK — BUY 📊 | 6 MONTHS THESIS
🎯 Q1 2026 | Rev $6.0B | EPS $23.41 vs $14.66 🟢 | Margin 69.1%
💡 Consensus estimated EPS of $14.66 for the quarter, while actual was $23.41; the market-implied forward PE of 55.6x is based on outdated estimates that will be revised up, potentially reducing the forward PE to sub-25x and triggering a re-rating.
📉 Reward/risk: 3.3:1
🏢 Business Quality: 8/10 - Explosive revenue growth with exceptionally high net margins (~60%), but cyclical and competitive risks temper the quality score.
📊 Valuation: fair-to-cheap — current PE of 55.6x is high on stale estimates, but on pro-forma annualized Q3 earnings the PE is ~23.7x; relative to historical...
🔮 Catalyst: Upward analyst estimate revisions following the earnings beat
💰 Entry: $2184.75, stop $2000, target $2800
📊 Our read: BUY. Full analysis →
https://stockduty.xyz/s/SNDK0619